BBOT
BridgeBio Oncology Therapeutics, Inc.
Company overview
- Market capitalization
- $305.46M
- Employees
- 106
- Latest publication
- 2026-09-29
About BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and phosphoinositide 3-kinase malignancies in the United States. The company develops BBO-8520, an orally bioavailable small molecule direct inhibitor, which is in Phase I clinical trial for the treatment of patients with KRASG12C mutant non-small cell lung cancer; and BBO-11818, an orally bioavailable small molecule pan-KRAS inhibitor, which is in Phase I clinical trial for the treatment of patients with KRAS G12D and KRAS G12V cell-derived xenograft models. It is also involved in the development of BBO-10203, an orally bioavailable small molecule, which is in Phase I clinical trial for the treatment of patients with HER2+ breast cancer, HR+/HER2- breast cancer, KRAS mutant colorectal cancer, and KRAS mutant non-small cell lung cancer; and precision oncology assets for patients with tumors. The company was incorporated in 2016 is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 186,000USD | 194,000USD | — | — | — | — | 156,000USD | — |
| Gross Profit | -186,000USD | -194,000USD | — | — | — | — | -156,000USD | — |
| Research Development | 39,802,000USD | 38,074,000USD | 35,052,000USD | 27,438,000USD | 20,635,000USD | 19,540,000USD | 17,889,000USD | 22,508,000USD |
| Selling General Administrative | 6,377,000USD | 5,334,000USD | 14,129,000USD | 2,655,000USD | 2,502,000USD | 2,339,000USD | 1,775,000USD | 1,363,000USD |
| Total Operating Expenses | 45,993,000USD | 43,408,000USD | 49,181,000USD | 30,093,000USD | 23,137,000USD | 21,879,000USD | 19,664,000USD | 23,871,000USD |
| Operating Income | -46,179,000USD | -43,408,000USD | -49,181,000USD | -30,093,000USD | -23,137,000USD | -21,879,000USD | -19,664,000USD | -23,871,000USD |
| Interest Income | 3,944,000USD | 4,424,000USD | 3,444,000USD | 1,666,000USD | 1,809,000USD | 2,133,000USD | 2,473,000USD | 1,766,000USD |
| Net Interest Income | 3,944,000USD | 4,424,000USD | 3,444,000USD | 1,666,000USD | 1,809,000USD | 2,133,000USD | 2,473,000USD | 1,766,000USD |
| Income Before Tax | -42,106,000USD | -38,797,000USD | -44,757,000USD | -28,435,000USD | -22,055,000USD | -19,687,000USD | -17,323,000USD | -21,823,000USD |
| Net Income | -42,106,000USD | -38,797,000USD | -44,757,000USD | -28,435,000USD | -22,055,000USD | -19,687,000USD | -17,323,000USD | -21,823,000USD |
| Net Income From Continuing Ops | -42,106,000USD | -38,797,000USD | -44,757,000USD | -28,435,000USD | -22,055,000USD | -19,687,000USD | -17,323,000USD | -21,823,000USD |
| Ebit | -46,179,000USD | -43,408,000USD | -49,181,000USD | -30,093,000USD | -23,137,000USD | -21,879,000USD | -19,664,000USD | -23,871,000USD |
| Ebitda | -45,993,000USD | -43,214,000USD | -49,000,000USD | -29,912,000USD | -23,083,000USD | -21,827,000USD | -19,612,000USD | -23,819,000USD |
| Depreciation And Amortization | 186,000USD | 194,000USD | 181,000USD | 181,000USD | 54,000USD | 52,000USD | 52,000USD | 52,000USD |
| Reconciled Depreciation | 186,000USD | 194,000USD | 181,000USD | 181,000USD | 54,000USD | 52,000USD | 52,000USD | 52,000USD |
| Total Other Income Expense Net | 4,073,000USD | 4,611,000USD | 4,424,000USD | 1,658,000USD | 1,082,000USD | 2,171,669USD | 2,341,000USD | 2,364,879USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | — | — |
| Cost Of Revenue | 610,000USD | — | — | — | — |
| Gross Profit | -610,000USD | — | — | — | — |
| Research Development | 121,199,000USD | 73,107,000USD | 56,286,000USD | — | — |
| Selling General Administrative | 24,620,000USD | 7,756,000USD | 8,485,000USD | 3,520USD | 74,326USD |
| Total Operating Expenses | 145,819,000USD | 80,863,000USD | 64,771,000USD | 3,520USD | 43,357USD |
| Operating Income | -145,819,000USD | -80,863,000USD | -64,771,000USD | -3,520USD | -43,357USD |
| Interest Income | 11,343,000USD | 6,377,000USD | 72,000USD | — | — |
| Net Interest Income | 11,343,000USD | 6,377,000USD | 72,000USD | — | — |
| Income Before Tax | -134,044,000USD | -74,275,000USD | -64,699,000USD | -3,520USD | -43,357USD |
| Net Income | -134,044,000USD | -74,275,000USD | -64,699,000USD | -3,520USD | -43,357USD |
| Net Income From Continuing Ops | -134,044,000USD | -74,275,000USD | -64,699,000USD | — | — |
| Ebit | -145,819,000USD | -80,863,000USD | -64,771,000USD | — | — |
| Ebitda | -145,209,000USD | -80,655,000USD | -64,679,000USD | -3,520USD | -43,357USD |
| Depreciation And Amortization | 610,000USD | 208,000USD | 92,000USD | — | — |
| Reconciled Depreciation | 610,000USD | 208,000USD | 92,000USD | — | — |
| Total Other Income Expense Net | 11,775,000USD | 8,183,901USD | 72,000USD | — | 3USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 376,706,000USD | 417,646,000USD | 448,381,000USD | 484,793,000USD | 151,253,000USD | 149,835,000USD | 194,424,196USD | 192,332,795USD |
| Cash And Equivalents | 54,063,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 225,711,000USD | 252,275,000USD | 425,460,000USD | 468,285,000USD | 131,398,000USD | 135,717,000USD | 1,697,777USD | 1,785,636USD |
| Short Term Investments | 171,648,000USD | 199,617,000USD | 51,773,000USD | 59,544,000USD | 99,880,000USD | 109,501,000USD | 124,780,000USD | — |
| Long Term Investments | 118,419,000USD | 136,617,000USD | — | — | — | — | — | — |
| Total Current Assets | 242,378,000USD | 266,502,000USD | 425,460,000USD | 476,010,000USD | 142,346,000USD | 141,327,000USD | 1,949,777USD | 2,041,802USD |
| Other Current Assets | 16,006,000USD | 14,081,000USD | -386,000USD | 7,499,000USD | 9,871,000USD | 5,570,000USD | 252,000USD | 256,166USD |
| Other Non Current Assets | 12,795,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 53,594,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 51,634,000USD | 43,260,000USD | 35,041,000USD | 35,712,000USD | 27,251,000USD | 24,056,000USD | 187,515USD | 126,690USD |
| Total Stockholder Equity | 323,112,000USD | 372,280,000USD | 411,096,000USD | 446,700,000USD | -227,733,000USD | -200,033,000USD | 188,716,681USD | 186,686,105USD |
| Total Equity Including Noncontrolling Interest | 323,112,000USD | — | — | — | — | — | — | — |
| Net Receivables | 661,000USD | 146,000USD | 386,000USD | 226,000USD | 1,077,000USD | 40,000USD | — | — |
| Property Plant Equipment Net | 2,982,000USD | 3,156,000USD | 3,286,000USD | 3,267,000USD | 3,449,000USD | 3,359,000USD | 490,000USD | — |
| Accounts Payable | 6,728,000USD | 12,090,000USD | 1,374,000USD | 3,650,000USD | 2,197,000USD | 3,653,000USD | 3,074,000USD | — |
| Short Term Debt | 554,000USD | 538,000USD | 522,000USD | 506,000USD | 320,000USD | 6,000USD | — | — |
| Common Stock | 8,000USD | 8,000USD | 8,000USD | 8,000USD | 196,514,069USD | 194,439,070USD | 192,449,802USD | 190,203,915USD |
| Retained Earnings | -455,127,000USD | -398,673,000USD | -356,567,000USD | -317,770,000USD | -273,013,000USD | -244,578,000USD | -3,733,121USD | -3,517,810USD |
| Accumulated Other Comprehensive Income | -959,000USD | -981,000USD | 16,000USD | 36,000USD | 51,000USD | 191,000USD | — | — |
| Total Liab | — | 45,366,000USD | 37,285,000USD | 38,093,000USD | 378,986,000USD | 349,868,000USD | 5,707,515USD | 5,646,690USD |
| Other Current Liab | — | 30,631,999USD | 33,145,000USD | 31,556,000USD | 24,734,000USD | 20,397,000USD | 187,515USD | 126,690USD |
| Capital Stock | — | 8,000USD | 8,000USD | 8,000USD | 0USD | 0USD | 0USD | — |
| Cash | — | 52,658,000USD | 373,687,000USD | 408,741,000USD | 31,518,000USD | 26,216,000USD | 1,697,777USD | 1,785,636USD |
| Net Debt | — | -50,014,000USD | -370,921,000USD | -405,854,000USD | -28,684,000USD | -23,567,000USD | -1,697,777USD | -1,785,636USD |
| Short Long Term Debt Total | — | 2,644,000USD | 2,766,000USD | 2,887,000USD | 2,834,000USD | 2,649,000USD | — | — |
| Property Plant Equipment Gross | — | 3,156,000USD | 3,286,000USD | 3,267,000USD | 3,449,000USD | 3,359,000USD | 490,000USD | — |
| Common Stock Shares Outstanding | — | 80,032,000shares | 31,144,775shares | 23,509,000shares | 23,509,000shares | 23,509,000shares | 16,636,000shares | 23,509,000shares |
| Non Current Assets Total | — | 151,144,000USD | 22,921,000USD | 8,783,000USD | 8,907,000USD | 8,508,000USD | 192,474,419USD | 190,290,992USD |
| Non Current Liabilities Total | — | 2,106,000USD | 2,244,000USD | 2,381,000USD | 351,735,000USD | 325,812,000USD | 5,520,000USD | 5,520,000USD |
| Non Currrent Assets Other | — | 11,239,000USD | 18,803,000USD | 5,516,000USD | 5,458,000USD | 5,149,000USD | 25,128USD | 87,588USD |
| Net Working Capital | — | 223,242,000USD | 397,355,000USD | 440,298,000USD | 115,095,000USD | 117,271,000USD | 139,113,000USD | — |
| Unclassified Non Current Liabilities | — | 2,106,000USD | 2,244,000USD | 2,381,000USD | 351,735,000USD | 325,812,000USD | 5,520,000USD | 5,520,000USD |
| Unclassified Equity | — | 771,918,000USD | 767,631,000USD | 764,418,000USD | -151,285,069USD | -150,085,070USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | — | -124,780,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | — | 191,959,291USD | 190,203,404USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -3,074,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 448,381,000USD | 194,424,196USD | 332,894USD | 144,578USD | 144,281USD |
| Other Current Assets | -386,000USD | 252,000USD | 1,964,000USD | — | — |
| Total Liab | 37,285,000USD | 5,707,515USD | 396,463USD | 166,455USD | 162,638USD |
| Total Stockholder Equity | 411,096,000USD | 188,716,681USD | -63,569USD | -21,877USD | -18,357USD |
| Other Current Liab | 33,145,000USD | 187,515USD | 326,368USD | 123,349USD | 125,677USD |
| Common Stock | 8,000USD | 192,449,802USD | 460USD | 288USD | 288USD |
| Capital Stock | 8,000USD | 0USD | 0USD | — | — |
| Retained Earnings | -356,567,000USD | -3,733,121USD | -88,569USD | -46,877USD | -43,357USD |
| Cash | 373,687,000USD | 1,697,777USD | 250,000USD | — | — |
| Cash And Short Term Investments | 425,460,000USD | 1,697,777USD | — | — | — |
| Total Current Assets | 425,460,000USD | 1,949,777USD | 3,937,000USD | — | — |
| Total Current Liabilities | 35,041,000USD | 187,515USD | 396,463USD | 166,455USD | 162,638USD |
| Net Debt | -370,921,000USD | -1,697,777USD | 70,095USD | 43,106USD | 36,961USD |
| Short Term Debt | 522,000USD | — | 70,095USD | 43,106USD | 36,961USD |
| Short Long Term Debt Total | 2,766,000USD | — | 70,095USD | 43,106USD | 36,961USD |
| Short Term Investments | 51,773,000USD | 124,780,000USD | 0USD | — | — |
| Net Receivables | 386,000USD | — | — | — | — |
| Accounts Payable | 1,374,000USD | 3,074,000USD | 575,000USD | — | — |
| Property Plant Equipment Net | 3,286,000USD | 490,000USD | 596,000USD | — | — |
| Property Plant Equipment Gross | 3,286,000USD | 490,000USD | — | — | — |
| Accumulated Other Comprehensive Income | 16,000USD | — | — | — | — |
| Common Stock Shares Outstanding | 31,144,775shares | 16,636,000shares | 20,485,000shares | 20,485,000shares | 20,485,000shares |
| Non Current Assets Total | 22,921,000USD | 192,474,419USD | 332,894USD | 144,578USD | 144,281USD |
| Non Current Liabilities Total | 2,244,000USD | 5,520,000USD | 104,808,000USD | — | — |
| Non Currrent Assets Other | 22,789,000USD | 25,128USD | 332,894USD | 144,578USD | 144,281USD |
| Net Working Capital | 397,355,000USD | 139,113,000USD | -12,838,000USD | — | — |
| Unclassified Non Current Assets | -3,154,000USD | 191,959,291USD | — | — | — |
| Unclassified Non Current Liabilities | 2,244,000USD | 5,520,000USD | 104,808,000USD | — | — |
| Unclassified Equity | 767,631,000USD | — | — | — | — |
| Unclassified Current Assets | — | -124,780,000USD | 1,723,000USD | — | — |
| Unclassified Current Liabilities | — | -3,074,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -42,106,000USD | -38,797,000USD | -44,757,000USD | -28,435,000USD | -487,392USD | 1,953,176USD | -17,323,000USD | 2,212,536USD |
| Depreciation | 186,000USD | 194,000USD | 416,000USD | 181,000USD | 54,000USD | 52,000USD | 156,000USD | 52,000USD |
| Stock Based Compensation | 3,871,000USD | 2,946,000USD | 2,833,081USD | 875,000USD | 57,919USD | 77,400USD | 77,400USD | 77,400USD |
| Other Non Cash Items | 3,797,000USD | -89,000USD | -36,700,570USD | -389,000USD | -325,413USD | -2,245,887USD | -33,718,956USD | -2,442,279USD |
| Change In Working Capital | 2,206,000USD | -6,488,000USD | 10,415,116USD | 4,475,000USD | 20,244USD | 127,452USD | 11,541,054USD | 123,244USD |
| Total Cash From Operating Activities | -35,917,000USD | -42,234,000USD | -70,626,454USD | -23,293,000USD | -734,642USD | -87,859USD | -39,344,902USD | -29,099USD |
| Capital Expenditures | -24,000USD | -73,000USD | -532,996USD | -231,000USD | -162,000USD | -10,000USD | -38,998USD | -14,000USD |
| Free Cash Flow | -35,941,000USD | -42,307,000USD | -71,159,450USD | -23,524,000USD | -734,642USD | -87,859USD | -39,383,900USD | -29,099USD |
| Investments | -285,383,000USD | 7,839,000USD | 40,555,000USD | 9,639,000USD | 15,368,000USD | 25,556,000USD | 3,024,000USD | -151,502,000USD |
| Total Cashflows From Investing Activities | -285,407,000USD | 7,766,000USD | 65,562,000USD | 9,639,000USD | — | — | 37,914,000USD | — |
| Total Cash From Financing Activities | 295,000USD | -586,000USD | 383,988,000USD | 18,956,000USD | -404,000USD | 52,000USD | 19,776,403USD | 199,591,000USD |
| Change In Cash | -321,029,000USD | -35,054,000USD | 408,076,769USD | 5,302,000USD | -734,642USD | -87,859USD | -28,863USD | -29,099USD |
| Begin Period Cash Flow | 373,687,000USD | 408,873,000USD | 664,231USD | 26,348,000USD | 1,697,777USD | 1,785,636USD | 1,814,499USD | 1,843,598USD |
| End Period Cash Flow | 52,658,000USD | 373,819,000USD | 408,741,000USD | 31,650,000USD | 963,135USD | 1,697,777USD | 1,785,636USD | 1,814,499USD |
| Other Cashflows From Financing Activities | -121,000USD | -586,000USD | -11,691,000USD | 18,956,000USD | — | 187,040,147USD | 1,062,000USD | — |
| Unclassified Operating Cash Flow | -3,871,000USD | — | -2,833,081USD | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 22,222,000USD | 0USD | 0USD | 0USD | 199,591,000USD |
| Other Cashflows From Investing Activities | — | 25,007,000USD | — | -9,639,000USD | — | — | 2,406,000USD | — |
| Unclassified Investing Cash Flow | — | -25,007,000USD | 25,539,996USD | 9,870,000USD | — | — | 32,522,998USD | — |
| Unclassified Financing Cash Flow | — | — | 395,679,000USD | -22,222,000USD | — | -186,988,147USD | 18,714,403USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Net Income | -134,044,000USD | 7,599,512USD | -41,692USD | -3,520USD | -74USD |
| Depreciation | 610,000USD | 208,000USD | 92,000USD | — | — |
| Stock Based Compensation | 5,873,000USD | 271,572USD | 16,465,000USD | — | — |
| Other Non Cash Items | 7,234,000USD | -8,530,291USD | 26,692USD | 3,520USD | 74USD |
| Change In Working Capital | 6,433,000USD | -104,613USD | 15,000USD | — | — |
| Total Cash From Operating Activities | -113,894,000USD | -763,820USD | -52,079,000USD | — | — |
| Capital Expenditures | -606,000USD | -49,000USD | -414,000USD | 0USD | 0USD |
| Free Cash Flow | -114,500,000USD | -763,820USD | -52,493,000USD | — | — |
| Investments | 73,934,000USD | -120,530,000USD | -2,820,000USD | — | — |
| Total Cashflows From Investing Activities | 73,328,000USD | -184,000,000USD | — | — | — |
| Total Cash From Financing Activities | 383,402,000USD | 186,461,597USD | 55,124,000USD | — | — |
| Issuance Of Capital Stock | 22,222,000USD | 206,238,000USD | 55,124,000USD | — | — |
| Change In Cash | 342,836,000USD | 1,697,777USD | 225,000USD | — | — |
| Begin Period Cash Flow | 30,983,000USD | 250,000USD | 25,000USD | — | — |
| End Period Cash Flow | 373,819,000USD | 1,697,777USD | 250,000USD | 25,000USD | — |
| Other Cashflows From Financing Activities | -12,322,000USD | -578,550USD | — | — | — |
| Unclassified Financing Cash Flow | 373,502,000USD | -19,197,853USD | — | — | — |
| Unclassified Investing Cash Flow | — | -63,421,000USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | -68,636,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.